USP7 and chronic myelogenous leukemia, BCR-ABL1 positive: Phosphorylated USP7 gains increased deubiquitinating activity, thus promoting the nuclear exclusion of phosphatase and tensin homolog (PTEN), which disrupts PTEN’s tumor suppressive function in CML cells [32, 33].